The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 07, 2021
Filed:
Apr. 25, 2019
Applicant:
Genentech, Inc., South San Francisco, CA (US);
Inventors:
Isidro Hotzel, Brisbane, CA (US);
Teemu T. Junttila, San Mateo, CA (US);
Ji Li, South San Francisco, CA (US);
Justin Scheer, South San Francisco, CA (US);
Danielle Dicara, South San Francisco, CA (US);
Diego Ellerman, San Francisco, CA (US);
Christoph Spiess, Mountain View, CA (US);
Paul J. Carter, Hillsborough, CA (US);
Assignee:
Genentech, Inc., South San Francisco, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12P 21/06 (2006.01); C12P 21/04 (2006.01); C12N 5/00 (2006.01); C12N 5/16 (2006.01); C12N 1/20 (2006.01); C07K 16/28 (2006.01); A61K 47/68 (2017.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 16/30 (2006.01); G01N 33/574 (2006.01); C07K 16/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/283 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61K 47/6849 (2017.08); A61K 47/6851 (2017.08); C07K 16/2809 (2013.01); C07K 16/2827 (2013.01); C07K 16/30 (2013.01); G01N 33/57492 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/33 (2013.01); C07K 2317/52 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/62 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); G01N 2333/70535 (2013.01);
Abstract
The present invention relates to anti-FcRH5 antibodies, including anti-FcRH5 antibodies comprising an FcRH5 binding domain and a CD3 binding domain (e.g., FcRH5 T cell-dependent bispecific (TDB) antibodies), and methods of using the same.